5(S),12(S)-DiHETE |
A natural bioactive lipid derived from AA |
25 µg |
35260-25 |
More Info
|
5(S),12(S)-DiHETE |
A natural bioactive lipid derived from AA |
50 µg |
35260-50 |
More Info
|
5(S),15(S)-DiHETE |
A dihydroxy fatty acid synthesized by 15-LO from 5(S)-HETE; chemotactic fo… |
100 µg |
35280-100 |
More Info
|
5(S),15(S)-DiHETE |
A dihydroxy fatty acid synthesized by 15-LO from 5(S)-HETE; chemotactic fo… |
25 µg |
35280-25 |
More Info
|
5(S),15(S)-DiHETE |
A dihydroxy fatty acid synthesized by 15-LO from 5(S)-HETE; chemotactic fo… |
50 µg |
35280-50 |
More Info
|
5(S),6(S)-DiHETE |
One of the four diastereomeric 5,6-dihydroxy acids produced from the non-e… |
100 µg |
35210-100 |
More Info
|
5(S),6(S)-DiHETE |
One of the four diastereomeric 5,6-dihydroxy acids produced from the non-e… |
25 µg |
35210-25 |
More Info
|
5(S),6(S)-DiHETE |
One of the four diastereomeric 5,6-dihydroxy acids produced from the non-e… |
50 µg |
35210-50 |
More Info
|
8(S),15(S)-DiHETE |
8(S),15(S)-DiHETE is formed when 15(S)-HETE is subjected to further oxidat… |
100 µg |
35370-100 |
More Info
|
8(S),15(S)-DiHETE |
8(S),15(S)-DiHETE is formed when 15(S)-HETE is subjected to further oxidat… |
25 µg |
35370-25 |
More Info
|
8(S),15(S)-DiHETE |
8(S),15(S)-DiHETE is formed when 15(S)-HETE is subjected to further oxidat… |
50 µg |
35370-50 |
More Info
|
12(S),13(S)-DiHODE |
An oxylipin |
100 µg |
35864-100 |
More Info
|
12(S),13(S)-DiHODE |
An oxylipin |
25 µg |
35864-25 |
More Info
|
12(S),13(S)-DiHODE |
An oxylipin |
50 µg |
35864-50 |
More Info
|
12(S),13(S)-DiHODE |
An oxylipin |
500 µg |
35864-500 |
More Info
|
7(S),10(S)-DiHOME |
An antibacterial hydroxy fatty acid; active against various food-borne pat… |
1 mg |
33447-1 |
More Info
|
7(S),10(S)-DiHOME |
An antibacterial hydroxy fatty acid; active against various food-borne pat… |
10 mg |
33447-10 |
More Info
|
7(S),10(S)-DiHOME |
An antibacterial hydroxy fatty acid; active against various food-borne pat… |
5 mg |
33447-5 |
More Info
|
7(S),17(S)-dihydroxy-8(E),10(Z),13(Z),15(E),19(Z)-Docosapentaenoic Acid |
A DPA-derived analog of the 17(S)-dihydroxy series of docosanoids known as… |
100 µg |
10546-100 |
More Info
|
7(S),17(S)-dihydroxy-8(E),10(Z),13(Z),15(E),19(Z)-Docosapentaenoic Acid |
A DPA-derived analog of the 17(S)-dihydroxy series of docosanoids known as… |
25 µg |
10546-25 |
More Info
|
7(S),17(S)-dihydroxy-8(E),10(Z),13(Z),15(E),19(Z)-Docosapentaenoic Acid |
A DPA-derived analog of the 17(S)-dihydroxy series of docosanoids known as… |
50 µg |
10546-50 |
More Info
|
SSE1806 |
A microtubule destabilizer; inhibits tubulin polymerization in a cell-free… |
1 mg |
39780-1 |
More Info
|
SSE1806 |
A microtubule destabilizer; inhibits tubulin polymerization in a cell-free… |
10 mg |
39780-10 |
More Info
|
SSE1806 |
A microtubule destabilizer; inhibits tubulin polymerization in a cell-free… |
5 mg |
39780-5 |
More Info
|
13(S),14(S)-epoxy Fluprostenol isopropyl ester |
A chiral enantiomer of 13,14-epoxy fluprostenol isopropyl ester whose phar… |
1 mg |
11170-1 |
More Info
|
13(S),14(S)-epoxy Fluprostenol isopropyl ester |
A chiral enantiomer of 13,14-epoxy fluprostenol isopropyl ester whose phar… |
10 mg |
11170-10 |
More Info
|
13(S),14(S)-epoxy Fluprostenol isopropyl ester |
A chiral enantiomer of 13,14-epoxy fluprostenol isopropyl ester whose phar… |
5 mg |
11170-5 |
More Info
|
22(S),23(S)-Homobrassinolide |
A synthetic brassinosteroid; increases the rooting percentage in P. abies… |
1 mg |
32884-1 |
More Info
|
22(S),23(S)-Homobrassinolide |
A synthetic brassinosteroid; increases the rooting percentage in P. abies… |
10 mg |
32884-10 |
More Info
|
22(S),23(S)-Homobrassinolide |
A synthetic brassinosteroid; increases the rooting percentage in P. abies… |
5 mg |
32884-5 |
More Info
|
22(S),23(S)-Homobrassinolide |
A synthetic brassinosteroid; increases the rooting percentage in P. abies… |
500 µg |
32884-500 |
More Info
|
S,S-hydroxy Bupropion (hydrochloride) |
An active metabolite of bupropion; inhibits dopamine and norepinephrine bu… |
1 mg |
35718-1 |
More Info
|
S,S-hydroxy Bupropion (hydrochloride) |
An active metabolite of bupropion; inhibits dopamine and norepinephrine bu… |
10 mg |
35718-10 |
More Info
|
S,S-hydroxy Bupropion (hydrochloride) |
An active metabolite of bupropion; inhibits dopamine and norepinephrine bu… |
25 mg |
35718-25 |
More Info
|
S,S-hydroxy Bupropion (hydrochloride) |
An active metabolite of bupropion; inhibits dopamine and norepinephrine bu… |
5 mg |
35718-5 |
More Info
|
(1S,3S)-3-Hydroxycyclopentane acetic acid |
A synthetic intermediate useful for pharmaceutical synthesis. |
50 mg |
11381-50 |
More Info
|
(1S,3S)-3-Hydroxycyclopentane acetic acid methyl ester |
A synthetic intermediate useful for pharmaceutical synthesis. |
50 mg |
11385-50 |
More Info
|
(1S,3S)-3-Hydroxycyclopentane carboxylic acid benzyl ester |
A synthetic intermediate useful for pharmaceutical synthesis. |
50 mg |
11369-50 |
More Info
|
ssK36 (trifluoroacetate salt) |
A peptide super-substrate for SETD2; methylated 70-fold more and 290-fold… |
1 mg |
37514-1 |
More Info
|
ssK36 (trifluoroacetate salt) |
A peptide super-substrate for SETD2; methylated 70-fold more and 290-fold… |
10 mg |
37514-10 |
More Info
|
ssK36 (trifluoroacetate salt) |
A peptide super-substrate for SETD2; methylated 70-fold more and 290-fold… |
25 mg |
37514-25 |
More Info
|
ssK36 (trifluoroacetate salt) |
A peptide super-substrate for SETD2; methylated 70-fold more and 290-fold… |
5 mg |
37514-5 |
More Info
|
(S)-SLV 319 |
A potent and selective CB1 receptor antagonist (Kis = 7.8 and 7,943 nM for… |
1 mg |
10009022-1 |
More Info
|
(S)-SLV 319 |
A potent and selective CB1 receptor antagonist (Kis = 7.8 and 7,943 nM for… |
10 mg |
10009022-10 |
More Info
|
(S)-SLV 319 |
A potent and selective CB1 receptor antagonist (Kis = 7.8 and 7,943 nM for… |
5 mg |
10009022-5 |
More Info
|
(1S,4S)-N-desmethyl Sertraline (hydrochloride) |
A metabolite of sertraline; inhibits 5-HT and DA uptake in the rat corpus… |
1 mg |
15916-1 |
More Info
|
(1S,4S)-N-desmethyl Sertraline (hydrochloride) |
A metabolite of sertraline; inhibits 5-HT and DA uptake in the rat corpus… |
10 mg |
15916-10 |
More Info
|
(1S,4S)-N-desmethyl Sertraline (hydrochloride) |
A metabolite of sertraline; inhibits 5-HT and DA uptake in the rat corpus… |
5 mg |
15916-5 |
More Info
|
(1'S,2'S)-Nicotine-1'-oxide |
The 1'S stereoisomer of the naturally occurring nicotine metabolite, nicot… |
100 mg |
16413-100 |
More Info
|
(1'S,2'S)-Nicotine-1'-oxide |
The 1'S stereoisomer of the naturally occurring nicotine metabolite, nicot… |
25 mg |
16413-25 |
More Info
|
(1'S,2'S)-Nicotine-1'-oxide |
The 1'S stereoisomer of the naturally occurring nicotine metabolite, nicot… |
50 mg |
16413-50 |
More Info
|
SSPalmM |
An ionizable cationic SSPalm; has been used in combination with other lipi… |
5 mg |
37377-5 |
More Info
|
SSPalmO-Phe |
An ionizable cationic self-degradable SSPalm (pKa = 5.97 in a TNS binding… |
1 mg |
37670-1 |
More Info
|
SSPalmO-Phe |
An ionizable cationic self-degradable SSPalm (pKa = 5.97 in a TNS binding… |
10 mg |
37670-10 |
More Info
|
SSPalmO-Phe |
An ionizable cationic self-degradable SSPalm (pKa = 5.97 in a TNS binding… |
5 mg |
37670-5 |
More Info
|
(1S,2S)-(+)-Pseudoephedrine |
An analytical reference standard that is categorized as an amphetamine; a… |
1 mg |
14209-1 |
More Info
|
(1S,2S)-(+)-Pseudoephedrine |
An analytical reference standard that is categorized as an amphetamine; a… |
5 mg |
14209-5 |
More Info
|
SSR 240612 |
A selective, non-peptide bradykinin B1 receptor antagonist (Kis = 0.48-0.7… |
1 mg |
25544-1 |
More Info
|
SSR 240612 |
A selective, non-peptide bradykinin B1 receptor antagonist (Kis = 0.48-0.7… |
10 mg |
25544-10 |
More Info
|
SSR 240612 |
A selective, non-peptide bradykinin B1 receptor antagonist (Kis = 0.48-0.7… |
25 mg |
25544-25 |
More Info
|
SSR 240612 |
A selective, non-peptide bradykinin B1 receptor antagonist (Kis = 0.48-0.7… |
5 mg |
25544-5 |
More Info
|
SSR 69071 |
A potent inhibitor of neutrophil elastase (Ki = 0.0168 nM for the human en… |
1 mg |
21477-1 |
More Info
|
SSR 69071 |
A potent inhibitor of neutrophil elastase (Ki = 0.0168 nM for the human en… |
10 mg |
21477-10 |
More Info
|
SSR 69071 |
A potent inhibitor of neutrophil elastase (Ki = 0.0168 nM for the human en… |
5 mg |
21477-5 |
More Info
|
SSR 128129E |
An FGFR inhibitor (IC50 = 1.9 nM); reduces FGF2-induced endothelial cell p… |
1 mg |
22128-1 |
More Info
|
SSR 128129E |
An FGFR inhibitor (IC50 = 1.9 nM); reduces FGF2-induced endothelial cell p… |
10 mg |
22128-10 |
More Info
|
SSR 128129E |
An FGFR inhibitor (IC50 = 1.9 nM); reduces FGF2-induced endothelial cell p… |
25 mg |
22128-25 |
More Info
|
SSR 128129E |
An FGFR inhibitor (IC50 = 1.9 nM); reduces FGF2-induced endothelial cell p… |
5 mg |
22128-5 |
More Info
|
9(S),12(S),13(S)-TriHODE |
An oxylipin; tumor levels are decreased compared with adjacent healthy tis… |
100 µg |
38950-100 |
More Info
|
9(S),12(S),13(S)-TriHODE |
An oxylipin; tumor levels are decreased compared with adjacent healthy tis… |
50 µg |
38950-50 |
More Info
|
9(S),10(S),13(S)-TriHOME |
An oxylipin derived from linoleic acid; has been detected in beer and in B… |
100 µg |
26768-100 |
More Info
|
9(S),12(S),13(S)-TriHOME |
An oxylipin with diverse biological activities; has been found in various… |
100 µg |
10005143-100 |
More Info
|
S-Sulfocysteine |
An NMDA receptor agonist; selective for the NMDA receptor over the AMPA re… |
10 mg |
34559-10 |
More Info
|
S-Sulfocysteine |
An NMDA receptor agonist; selective for the NMDA receptor over the AMPA re… |
25 mg |
34559-25 |
More Info
|
S-Sulfocysteine |
An NMDA receptor agonist; selective for the NMDA receptor over the AMPA re… |
5 mg |
34559-5 |
More Info
|